DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mabuterol
Mabuterol
Customs Tariff - Schedule
Pharmaceutical Appendix to the Tariff Schedule 2
CATO佳途科技- Cato Research Chemicals Inc
Drug and Medication Classification Schedule
Chapter 260-70 WAC EQUINE MEDICATION PROGRAM
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Pharmaceutical Composition and Dosage Forms for Administration of Hydrophobic Drugs
178CSR1 Title 178 Legislative Rule West Virginia Racing Commission
European Patent Office
Stembook 2018.Pdf
Airway Redox Homeostasis and Inflammation Gone Awry
2021 Equine Prohibited Substances List
(12) Patent Application Publication (10) Pub. No.: US 2010/0184806 A1 Barlow Et Al
Drug/Substance Trade Name(S)
The Iditarod Trail Committee Exists to Preserve the Tradition of Dog Mushing in Alaska by Staging the World Premier Sled Dog Race Along the Iditarod Trail
Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Rana Dadashova
Top View
Uniform Classification Guidelines for Foreign Substances, Version 7.00
Marrakesh Agreement Establishing the World Trade Organization
2020 Equine Prohibited Substances List
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Customs Tariff - Schedule
2019 Equine Prohibited Substances List
( 12 ) United States Patent
Customs Tariff - Schedule Xxi - 1
Asthma and Exercise-Induced Respiratory Disorders in Athletes
Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule
KENTUCKY HORSE RACING Chapter: \810\008.020REG
WO 2015/119624 Al 13 August 2015 (13.08.2015) P O P C T
Human Neurogenesis Assay: MKC-231 + AMPA
Literature Search Strategy for Treatment of Stable
Drugs and Medications
Agency Solicitation Package
2019 Banned Substances List.Pdf
Harmonized Tariff Schedule of the United States (2006) (Rev
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
WO 2015/058117 Al 23 April 2015 (23.04.2015) P O P C T
Asthma and Exercise-Induced Respiratory Disorders in Athletes
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
AERC Drug Rule Appendices
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
Substance Activity
(12) United States Patent (10) Patent No.: US 7,838,552 B2 Davis Et Al
2016 AGSC DRUG TESTING LIST RCI Class 1 Drugs